middl
east
respiratori
syndrom
coronaviru
merscov
lineag
first
identifi
serolog
survey
identifi
merscovspecif
antibodi
seropreval
adult
dromedari
camel
camelu
dromedariu
mani
countri
middl
east
africa
moreov
merscov
viral
rna
detect
nasal
swab
dromedari
qatar
oman
saudi
arabia
egypt
unit
arab
emir
uae
confirm
mer
human
case
iran
jordan
kuwait
lebanon
oman
saudi
arabia
qatar
uae
yemen
epidemiolog
link
camel
indic
camel
potenti
sourc
human
infect
alpaca
vicugna
paco
llama
lama
glama
also
suscept
experiment
merscov
infect
alpaca
found
natur
infect
present
highest
merscov
preval
human
document
saudi
arabia
report
world
health
organ
wherea
case
report
israel
despit
occurr
humancamel
contact
approxim
bedouin
tradit
seminomad
pastoralist
popul
inhabit
negev
desert
breed
camel
sheep
goat
estim
dromedari
camel
popul
israel
addit
largest
herd
alpaca
llama
outsid
south
america
negev
sinc
viru
circul
surround
countri
aim
assess
presenc
merscov
specif
antibodi
viral
rna
among
camelid
israel
total
blood
sampl
dromedari
camel
alpaca
llama
collect
tabl
fig
sampl
camel
farm
locat
negev
one
central
israel
one
north
fig
camel
includ
male
femal
age
rang
month
year
alpaca
lama
sampl
one
farm
locat
negev
alpaca
includ
femal
male
age
rang
month
year
lama
includ
femal
male
age
rang
year
year
total
nasal
swab
camel
alpaca
llama
collect
januari
novemb
camel
sampl
collect
femal
male
age
month
year
alpaca
lama
one
farm
negev
viru
neutral
antibodi
test
vnt
gold
standard
assay
serolog
diagnosi
merscov
infect
camel
alpaca
llama
sera
test
dilut
presenc
neutral
antibodi
merscov
viru
neutral
test
vnt
briefli
sera
heatinactiv
incub
min
twofold
serial
dilut
sera
prepar
plate
start
dilut
sera
react
dilut
consid
posit
live
merscov
dilut
iscov
modifi
dulbecco
medium
imdm
supplement
penicillin
streptomycin
fb
dilut
tcid
ml
subsequ
viru
suspens
ad
well
plate
plate
incub
h
next
virusserum
mixtur
incub
well
plate
contain
vero
cell
h
follow
wash
pb
incub
fb
day
cytopath
effect
score
merscov
antibodi
screen
elisa
euroimmun
ag
lubeck
germani
accord
elisa
manufactur
instruct
briefli
dilut
serum
sampl
incub
elisa
plate
well
coat
merscov
antigen
posit
neg
calibr
sampl
includ
antibodi
detect
ad
peroxidaselabel
rabbit
anticamel
igg
result
report
optic
densiti
od
ratio
calcul
od
valu
sampl
divid
calibr
od
valu
use
cutoff
valu
recommend
elisa
kit
manufactur
ratio
consid
neg
consid
borderlin
consid
posit
borderlin
react
sera
includ
comparison
swab
specimen
suspend
ml
pb
incub
h
room
temperatur
clarifi
centrifug
rpm
min
supernat
recov
extract
store
analysi
total
nucleic
acid
extract
swab
sampl
use
invisorb
spin
viru
rna
mini
kit
stratec
molecular
gmbh
berlin
germani
accord
manufactur
instruct
extract
rna
test
presenc
merscov
rna
realtim
revers
transcriptionquantit
polymeras
chain
reaction
qrt
rtpcr
hydrolysi
probe
assay
use
bio
rad
cfx
real
time
detect
system
bio
rad
hercul
ca
usa
primer
probe
encompass
upstream
envelop
gene
upe
serolog
data
enter
excel
worksheet
analyz
use
excel
function
result
excel
verifi
use
public
access
statist
softwar
http
wwwmedcalcorgcalcdiagnost
testphp
http
vassarstatsnetkappahtml
http
vassarstatsnet
merscov
specif
antibodi
isra
camel
analyz
use
qabboa
rahat
azem
hura
mitzp
two
serolog
assay
vnt
elisa
year
sera
analyz
vnt
gold
standard
perform
refer
laboratori
expans
screen
activ
israel
subsequ
year
sera
analyz
elisa
also
enabl
safeti
requir
thu
assay
perform
parallel
fig
show
neutral
titer
percentag
posit
confid
level
ci
detect
two
assay
per
year
vnt
perform
sera
collect
elisa
perform
sera
collect
initi
test
camel
sera
obtain
use
vnt
camel
adult
year
thu
analysi
infect
age
possibl
merscov
neutral
antibodi
year
show
seroposit
point
estim
proport
pep
ci
confid
level
cl
seroposit
seem
drop
sera
analyz
elisa
vnt
fig
b
seropreval
merscov
antibodi
obtain
use
elisa
significantli
differ
obtain
use
vnt
pep
cl
overlap
fig
camel
sera
collect
southern
part
israel
except
farm
no
tabl
fig
northern
central
israel
respect
one
camel
serum
farm
posit
sensit
specif
two
serolog
assay
vnt
elisa
determin
camel
sera
test
parallel
two
assay
take
vnt
goldstandard
sensit
elisa
compar
vnt
assay
ci
specif
cl
perform
kappa
evalu
agreement
elisa
vnt
test
receiv
valu
ci
cl
defin
cohen
show
perfect
strength
agreement
overal
camel
vnt
posit
neutral
titer
fig
camel
low
antibodi
titer
measur
camel
high
antibodi
titer
antibodi
detect
titer
camel
blood
collect
alpaca
llama
test
elisa
vnt
fig
use
elisa
alpaca
llama
sera
show
seropreval
respect
posit
use
vnt
alpaca
llama
posit
pep
ci
ci
respect
vnt
titer
rel
low
rang
fig
two
camel
sampl
farm
alpaca
lama
neg
merscov
vnt
elisa
nasal
swab
camel
alpaca
llama
collect
januari
decemb
analyz
presenc
merscov
rna
nasal
swab
neg
presenc
merscov
rna
provid
evid
activ
circul
least
merscov
negev
camel
present
first
serolog
molecular
survey
merscov
infect
among
isra
camelid
camel
show
averag
merscov
seropreval
vnt
averag
seropreval
elisa
without
detect
viral
rna
nasal
swab
camel
presenc
virusspecif
neutral
antibodi
suggest
isra
camel
expos
merscov
past
vnt
assay
sensit
elisa
sensit
compar
vnt
assay
featur
could
relat
fact
elisa
coat
antigen
merscov
spike
protein
wherea
vnt
assay
employ
complet
virion
could
reveal
antibodi
viral
protein
altern
wherea
elisa
detect
igg
vnt
detect
isotyp
antibodi
could
igg
igm
iga
vnt
assay
also
specif
elisa
calcul
specif
compar
vnt
addit
higher
strength
vnt
assay
compar
elisa
might
attribut
fact
borderlin
sera
elisa
consid
period
proport
camel
sera
high
vnt
titer
israel
much
lower
proport
sera
high
vnt
titer
surround
countri
saudi
arabia
qatar
uae
oman
egypt
jordan
reach
moreov
proport
sera
low
vnt
titer
israel
wherea
surround
countri
sera
low
vnt
titer
mean
merscov
seropreval
israel
lower
surround
countri
differ
seroposit
year
israel
might
relat
camel
includ
random
sampl
contrast
low
seropreval
probabl
viru
circul
document
canari
island
present
studi
show
first
time
presenc
merscov
antibodi
natur
infect
llama
elisa
vnt
studi
isra
alpaca
llama
respect
seroposit
use
vnt
assay
use
elisa
alpaca
llama
respect
detect
seroposit
two
camel
cohous
llama
alpaca
neg
antibodi
viral
rna
use
two
serolog
assay
pcr
respect
previous
merscov
neutral
antibodi
detect
alpaca
qatar
similar
find
lower
neutral
antibodi
titer
document
alpaca
experiment
infect
llama
camel
use
merscov
specif
rtpcr
detect
merscov
genom
rna
nasal
swab
camel
alpaca
llama
period
provid
evid
activ
merscov
circul
altogeth
rel
low
preval
antibodi
merscov
low
antibodi
titer
absenc
viral
rna
nasal
swab
absenc
diseas
human
indic
limit
merscov
circul
isra
camelid
time
survey
